EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting α-synuclein post-translational modifications in Parkinson’s disease

Jaquelini B Canever, Ericks Sousa Soares, Núbia C P de Avelar, Helena I Cimarosti

Behavioural Brain Research · 2023-02 · 439 · 114204

DOI: 10.1016/j.bbr.2022.114204 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Behavioural Brain Research, 2023-02. Verfasst von Jaquelini B Canever und 3 weiteren Autor:innen. Beteiligte Einrichtung: Post-Graduate Program in Neuroscience, Federal University of Santa Catarina (UFSC), Florianópolis, Santa Catarina, Brazil; Laboratory of Aging, Resou…. Hauptthemen laut MEDLINE: Parkinson Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 215 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the nigrostriatal pathway. Although the exact mechanisms underlying PD are still not completely understood, it is well accepted that α-synuclein plays key pathophysiological roles as the main constituent of the cytoplasmic inclusions known as Lewy bodies. Several post-translational modifications (PTMs), such as the best-known phosphorylation, target α-synuclein and are thus implicated in its physiological and pathological functions. In this review, we present (1) an overview of the pathophysiological roles of α-synuclein, (2) a descriptive analysis of α-synuclein PTMs, including phosphorylation, ubiquitination, SUMOylation, acetylation, glycation, truncation, and O-GlcNAcylation, as well as (3) a brief summary on α-synuclein PTMs as potential biomarkers for PD. A better understanding of α-synuclein PTMs is of paramount importance for elucidating the mechanisms underlying PD and can thus be expected to improve early detection and monitoring disease progression, as well as identify promising new therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseNeurodegenerative DiseasesHumansalpha-SynucleinProtein Processing, Post-TranslationalLewy Bodies

Stichwörter der Autor:innen

AcetylationGlycationO-GlcNAcylationPhosphorylationSUMOylationTruncationUbiquitinationα-synuclein

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Post-Graduate Program in Neuroscience, Federal University of Santa Catarina (UFSC), Florianópolis, Santa Catarina, Brazil; Laboratory of Aging, Resources and Rheumatology, UFSC, Araranguá, Santa Catarina, Brazil.
  • Post-Graduate Program in Pharmacology, UFSC, Florianópolis, Santa Catarina, Brazil.
  • Laboratory of Aging, Resources and Rheumatology, UFSC, Araranguá, Santa Catarina, Brazil.
  • Post-Graduate Program in Neuroscience, Federal University of Santa Catarina (UFSC), Florianópolis, Santa Catarina, Brazil; Post-Graduate Program in Pharmacology, UFSC, Florianópolis, Santa Catarina, Brazil. Electronic a…

Zitieren

APA

Canever, J. B., Soares, E. S., de Avelar, N. C. P., & Cimarosti, H. I. (2023). Targeting α-synuclein post-translational modifications in Parkinson’s disease. Behavioural Brain Research, 439, 114204. https://doi.org/10.1016/j.bbr.2022.114204

Vancouver

Canever JB, Soares ES, de Avelar NCP, Cimarosti HI. Targeting α-synuclein post-translational modifications in Parkinson’s disease. Behavioural Brain Research. 2023;439:114204. doi:10.1016/j.bbr.2022.114204

BibTeX
@article{Canever2023,
  author = {Canever, Jaquelini B and Soares, Ericks Sousa and de Avelar, Núbia C P and Cimarosti, Helena I},
  title = {Targeting α-synuclein post-translational modifications in Parkinson’s disease},
  journal = {Behavioural Brain Research},
  year = {2023},
  volume = {439},
  pages = {114204},
  doi = {10.1016/j.bbr.2022.114204}
}
Kostenlos starten →